Candriam Equities L Biotechnology, V - Capitalisation/  LU0317020203  /

Fonds
NAV9/6/2024 Chg.-25.1299 Type of yield Investment Focus Investment company
2,217.8201USD -1.12% reinvestment Equity Candriam